Lp(a): a New Pathway to Target?

Purpose of Review Over the past decades, genetic and observational evidence has positioned lipoprotein(a) as novel important and independent risk factor for cardiovascular disease (ASCVD) and aortic valve stenosis. Recent Findings As Lp(a) levels are determined genetically, lifestyle interventions h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current atherosclerosis reports 2022-11, Vol.24 (11), p.831-838
Hauptverfasser:	Nurmohamed, Nick S., Kraaijenhof, Jordan M., Stroes, Erik S. G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiology Aortic Valve Stenosis Cardiology Cardiovascular Diseases - drug therapy Cholesterol, LDL Humans Lipoprotein(a) - genetics Medicine Medicine & Public Health Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) Oligonucleotides, Antisense - therapeutic use Risk Factors RNA, Messenger Section Editors Topical Collection on Nonstatin Drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!